SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-08-027055
Filing Date
2008-05-08
Accepted
2008-05-08 17:12:45
Documents
11
Period of Report
2008-03-29

Document Format Files

Seq Description Document Type Size
1 v113009_10q.htm 10-Q 1554961
2 v113009_ex10-1.htm EX-10.1 121984
3 v113009_ex10-2.htm EX-10.2 110729
4 v113009_ex10-3.htm EX-10.3 105771
5 v113009_ex10-4.htm EX-10.4 112202
6 v113009_ex10-5.htm EX-10.5 111715
7 v113009_ex10-6.htm EX-10.6 118150
8 v113009_ex31-1.htm EX-31.1 17800
9 v113009_ex31-2.htm EX-31.2 17779
10 v113009_ex32-1.htm EX-32.1 8400
11 v113009_ex32-2.htm EX-32.2 8232
  Complete submission text file 0001144204-08-027055.txt   2289234
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 201-802-4000
PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10827 | Film No.: 08814992
SIC: 2834 Pharmaceutical Preparations